{"name":"EG 427","slug":"eg-427","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPZnAyMUNfck5adjRhNXhfd2x5aVFrY1kwdmZTTlZsZjIzS1Y1dHhFUHJTaFk1ZC12MUVMazdfejBKMmducVJQZklGQU96emRXcVBnVmsyWUVRNGxud2M2eUpDemVFYV9vQ2ZzeWZUVGpBMUpiUnpsVVllbTF4dUJPVllNbmJvUHdPTGUtNmp0UmFldXlmTFFuUENKWTNISzIzNVctNXYwNVVNdlFTYUdIMEJvektFQThhNTNPOHBDUzYya1RKclNURzc5M1lXQ1p0RDhKLVltd053MkZiWjlHMGFGeTFTVWdEdlAtbm1qTDl0cUlDR0pn?oc=5","date":"2026-02-24","type":"pipeline","source":"EU-Startups","summary":"Amid €65 billion lost each year to stroke and dementia in Germany, nyra health secures €20 million to scale digital neurotherapy - EU-Startups","headline":"Amid €65 billion lost each year to stroke and dementia in Germany, nyra health secures €20 million to scale digital neur","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQVDliSDVPZzBIZmQwWHVWMVZjRmUzYnBkaTA5WFlmb3VnZ2toMDYxa3pFZlNtdEdRUVQ5ZEFNb3NXRGtDaG1Mc2wxNko4SDNybDZvR0ZYWUwzRlZPNEFuaXJpN1dKQncybk5VdWdJM28wdmw2ZmY4amhaSmctbmpKX1RvTEMtR0dNMFVNMG5DRmotY1lsSUppWUc2Ukc5TUdLbGFFVVdzWFhvdXE5MG1mSVFpbDlTTktXN1E?oc=5","date":"2026-02-19","type":"pipeline","source":"Inside Precision Medicine","summary":"Riding the Gene Therapy Rollercoaster Into 2026 - Inside Precision Medicine","headline":"Riding the Gene Therapy Rollercoaster Into 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNWlBqeTIzQVVWdW9HWHlBRkFLRkctR2tKVEVhS2w4Ukx6RGdCSGM1UlFncG1EUGRHTFFEU2Rsd29TbWlncVdTS1NvRmxhRVVfUG9mRGRrRVZrVTBNYTVpSXJDU3BWMGxWTjZPeUJVaVUtMWZ0bTdUUXppbGc0RTVNeGN5akVpbUluLWY4R1F1TDVBUktiS0lwUi1SOTN6TXpFZlFleXBuam1EOE41d2Nid1dqM2s?oc=5","date":"2026-02-17","type":"pipeline","source":"European Biotechnology Magazine","summary":"Newron secured €38m to test a potential new class in schizophrenia - European Biotechnology Magazine","headline":"Newron secured €38m to test a potential new class in schizophrenia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQeE53a2VMVzltYWZHZTl6R080cjZsMTV6b2x6c0NYSnFOUkVyM3o2c2k3Z1ZodEtZRzdrREhlWHg2cmRLNTl5aVBpSnNPVjhKdnc4Yms4eWJmYjVNa3hiRW9kdUk4ODIwYnE0OUYtdGhFY25nZ21sSkJTLVh1b2VkdTNsMEhmMGpHYS1FYXBoYUtndGo5WDVZQm91Zmp2Mnh4cGF6aWlwUEhKUlJuSzRVY3dxTjVjNERQQVU4TlpkTUNoR0ZTZlRTc2UxTFRmdXJBWmJjZw?oc=5","date":"2025-12-02","type":"pipeline","source":"EU-Startups","summary":"New approaches to ALS, Alzheimer’s and Parkinson’s receive support as Axoltis Pharma secures €18 million - EU-Startups","headline":"New approaches to ALS, Alzheimer’s and Parkinson’s receive support as Axoltis Pharma secures €18 million - EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFBpOTdVRkVZQVpsQURtU3plcGxZNDRqTWlzUEc2Y25DLWhiSXpYUXdPYW9Ka19Vb3JlRFk3azJNN1dHZW9tYkdhWG84UWFkc0pVSmRLUXZTN0RTRkZhSWxuTF9R?oc=5","date":"2025-06-24","type":"pipeline","source":"Labiotech.eu","summary":"Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem - Labiotech.eu","headline":"Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5VNkRQY3UyY0c5S2p3cnFnZTJEbk10d0NIRWM4UTVoSWM4Zzc1RF9zeEhIQ0xOalNVR2ZyN0ExYVBpczllZ0ZfWWgxVnh5V3FrY09DSlFHQ1RxelVLSDB3NVhmWmtzOVRqaFJDT09rVTFrSGNMT0UxRWZ3?oc=5","date":"2025-05-12","type":"pipeline","source":"Labiotech.eu","summary":"Pharma giants pull back on AAV research: what’s next for the gene therapy space? - Labiotech.eu","headline":"Pharma giants pull back on AAV research: what’s next for the gene therapy space?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOT2ZfWnVfcVhtRjg0bk5FQVNtOVJFMkRhOXFCejQtZWZjZjNKbTc4REs3aTh3aDlOVVF4RHFidGo3aEVnRXoxVE0yWURWMFNQMGpfQlExSGp6SGI5VkxYaHc1b1JCOXRnR1JaREhLeWwzcXk0SVRVRE9qN2tCZ0tCTEdfbFhjWXJ4d3JkWDg2MDZqUUM5YlFaNTEzZWQ?oc=5","date":"2025-03-31","type":"pipeline","source":"Pharma Voice","summary":"A recent gene therapy death shines a light on AAV safety - Pharma Voice","headline":"A recent gene therapy death shines a light on AAV safety","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNdDUyS3hseEtaalFLM2pYMHZSN1AwclU0Slo2emJLYXFZeHJ4N0RfUDlqOEhwU2lDQUdvUXFxbTJsQjNjc2FMcnZtbENQdk1nYzhVbEVNR1hMTzJXcS0zX1hYZHZzZ2QwS0IxZ2lvZDVwbWVNTVY0ekQwcEl5SXllX2t1MGpPcnk2VDhqU05KSU5XdlhmYWhOU3N6V1NLM1k5Ty1tSU1RN2VyNWw3UFJBR3VzM3ZFSm1hdXdhaXk1OF8xVngxYnVDV0JpWTZKZE1HczZhVHUta2xUY1R6WnpGRWcyOS1aTjFSUFE?oc=5","date":"2025-02-26","type":"trial","source":"Health Tech World","summary":"Startup news: £200m AI collab to transform UK diagnostics, €27m to accelerate spinal cord injury treatment trial, and more - Health Tech World","headline":"Startup news: £200m AI collab to transform UK diagnostics, €27m to accelerate spinal cord injury treatment trial, and mo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNRWZYZjN5VHJxUzQySFNlbzJ3RHBxdjF2OU9sVU9RUXRIYmNlY25ROXRNd2g1YzJ3ZnJYdUNQVmRlaUEyNVExMGpLaWdld1dyeFlTY0tJck9KeTlVQmxXWmJJQkpoaGJsbE5xdFlBNmFGdy1mNE04QmZmRmEzTkFGRHlZWVk5eG9vV0dVSQ?oc=5","date":"2025-02-21","type":"pipeline","source":"The Pharma Letter","summary":"EG 427 raises 27 million euros in Series B financing - The Pharma Letter","headline":"EG 427 raises 27 million euros in Series B financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9OMU0xaEFycFplR1FTcFdqQzdCeW1nRHRhOWg5cVBEeTRvY0twYXo5WWZnRy1mdUZlRjB5U05SQmVIUTRmVkdKSE5FemZGUUg5QUZV?oc=5","date":"2025-02-20","type":"pipeline","source":"FirstWord Pharma","summary":"French biotech clinches €27M to engineer herpes viral vectors for genetic payloads - FirstWord Pharma","headline":"French biotech clinches €27M to engineer herpes viral vectors for genetic payloads","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPRU1VRnJVdll3MEwtT1RLd3o0d29kX3VvVjlPNmJsWTdScnkxZk1PRFBoWjBmWFlLWTZRMmpSOFQ2cl9XUDVHcjNoSmVHNGlmMnpHYjY3WXBiTzQ2OU85WGptV25tajJrcmJIM3JETWdYSUxXbE13SFFqMkhnWnJyek1sMEZaSmsyeEp1cDFNOEhXSGV0aFRvbg?oc=5","date":"2025-02-20","type":"pipeline","source":"European Biotechnology Magazine","summary":"French EG 427 bags €27m in Series B financing - European Biotechnology Magazine","headline":"French EG 427 bags €27m in Series B financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNRkdIM2I3R0ptM1k1cUFPeERMUVd1UTRMbnNWT0NfX3hFS1oxMzh3ak1mQmt2QUlwU1U1Ql9ub3otRGpvYkNiejU1TnFiUU0xWm8wMW01bXBCaHBrVFZ1ejZKVGVrS0p6NmNuM3IwcmpyLVZ3NTl6T1lKa2ktb2ItUzZpc2VPUkhsTWViWDhxZG0wT2ZzTDdfZ3F6UVl3Njht?oc=5","date":"2024-12-24","type":"patent","source":"Wolters Kluwer","summary":"Dutch District Court upholds BMS’s apixaban patent - Wolters Kluwer","headline":"Dutch District Court upholds BMS’s apixaban patent","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}